Sort
172,184 grants matching “inflammation”
CIP Genomics Core
$1,025,863Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
$1,025,696Christine Marie Durand · Johns Hopkins University · U01 · FY2022 · AI
An innovative, non-thiazolidinedione pan-PPAR agonist therapeutic for alcoholic hepatitis: IND-enabling safety and toxicological evaluation
$1,025,643Prasad Manchem · Pleiogenix Inc. · R44 · FY2025 · AA
UTEP-UNM HSC ARCH PROGRAM ON BORDER ASTHMA
$1,025,385University Of Texas El Paso · S11 · FY2005 · ES
A Haplotype Map for Multiple Sclerosis
$1,025,276Stephen L Hauser · University Of California, San Francisco · R01 · FY2011 · NS
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research
$1,025,217Catherine M. Tangen · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Murine models of vascular remodeling
$1,025,072Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
The Neonatal Microbiome and Necrotizing Enterocolitis
$1,024,974Phillip I Tarr · Washington University · UH2 · FY2009 · AI
IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection
$1,024,942Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2024 · AI
Exploring roles of protein deamidation in oral inflammation
$1,024,914C Casey Chen · University Of Southern California · R35 · FY2020 · DE
IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection
$1,024,879Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2025 · AI
Development of IMYX-3 for the Treatment of Ulcerative Colitis
$1,024,862Christina Eng · Immunyx Pharma Usa Inc. · R44 · FY2025 · DK
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$1,024,796Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
The Thrifty Microbiome: The Role of the Gut Microbiota in Obesity in the Amish
$1,024,737Claire M Fraser-Liggett · University Of Maryland Baltimore · UH2 · FY2009 · DK
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,024,639Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2021 · HL
Novel Interactions Between the Immune and Neuroendocrine Systems
$1,024,566Dennis D. Taub · National Institute On Aging · Z01 · FY2008 · AG
Etiological Studies of Gastric Carcinoma
$1,024,383Pelayo Correa · Vanderbilt University · P01 · FY2012 · CA
Pre- and Peri-natal Predictors of Childhood Obesity
$1,024,170Emily Oken · Harvard Pilgrim Health Care, Inc. · R01 · FY2017 · HD
Mass Spectrometry Quantitation
$1,024,014Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2019 · ES
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,023,811Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2022 · HL
Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease
$1,023,733Jin Wang · Baylor College Of Medicine · U01 · FY2023 · AG
The Genetic and Biological Determinants of Environmental Airway Disease
$1,023,640David Schwartz · Environmental Health Sciences · Z01 · FY2007 · ES
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIV
$1,023,588Michael Jay Corley · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · MH
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$1,023,526Tomas G Neilan · Massachusetts General Hospital · R01 · FY2025 · HL
Pathophysiology of Acute Pain in Patients with Sickle Cell Disease
$1,023,525Swee Lay Thein · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL